ITM Isotopen Technologien München Overview
- Founded
- 2004

- Status
- Private
- Employees
- 50

- Latest Deal Type
- Debt
- Financing Rounds
- 5
ITM Isotopen Technologien München General Information
Description
Developer of novel radiopharmaceuticals and radiomedical devices. The company design and develops novel radiopharmaceuticals and radiomedical devices. The company products are rhenium-SCT for non-invasive skin cancer therapy and ITM rhenium-PTA/PTCA for endovascular brachytherapy.
Contact Information
- Lichtenbergstraße 1
- 85748 Munich
- Germany
ITM Isotopen Technologien München Timeline
ITM Isotopen Technologien München Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore ITM Isotopen Technologien München‘s full profile, request access.
Request a free trialITM Isotopen Technologien München Executive Team (5)
ITM Isotopen Technologien München Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000000 00000000 | ITM Isotopen Technologien München | Chief Executive Officer & Chairman | 000 0000 |
ITM Isotopen Technologien München Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialITM Isotopen Technologien München Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore ITM Isotopen Technologien München‘s full profile, request access.
Request a free trial